{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:45:54Z","timestamp":1776851154382,"version":"3.51.2"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000006124","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T15:05:01Z","timestamp":1487171101000},"page":"e6124","source":"Crossref","is-referenced-by-count":16,"title":["Different dosages of mifepristone versus enantone to treat uterine fibroids"],"prefix":"10.1097","volume":"96","author":[{"given":"Chongdong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilu","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-44-20210309","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"R2-44-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00003081-200106000-00020","article-title":"Management options for uterine fibroids","volume":"44","author":"Gross","year":"2001","journal-title":"Clin Obstet Gynaecol"},{"key":"R3-44-20210309","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.2781282","article-title":"Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor","volume":"245","author":"Baulieu","year":"1989","journal-title":"Science"},{"key":"R4-44-20210309","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R5-44-20210309","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systematic review of mifepristone for the treatment of uterine leiomyomata","volume":"103","author":"Steinauer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R6-44-20210309","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31818aa930","article-title":"Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial","volume":"112","author":"Carbonell Esteve","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R7-44-20210309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJWH.S28103","article-title":"Mifepristone 2.5\u200amg versus 5\u200amg daily in the treatment of leiomyoma before surgery","volume":"4","author":"Carbonell Esteve","year":"2012","journal-title":"Int J Womens Health"},{"key":"R8-44-20210309","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2011.12.018","article-title":"Treatment of uterine myoma with 5 or 10\u200amg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial","volume":"161","author":"Esteve","year":"2012","journal-title":"Eur J Obstet Gynecol"},{"key":"R9-44-20210309","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmig.2005.01.022","article-title":"Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas","volume":"12","author":"Eisinger","year":"2005","journal-title":"J Minim Invasive Gynecol"},{"key":"R10-44-20210309","first-page":"243","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R11-44-20210309","first-page":"513","article-title":"Regression of uterine leiomyomata in response to the antiprogesterone RU486","volume":"76","author":"Murphy","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-44-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"key":"R13-44-20210309","first-page":"624","article-title":"Treatment of uterine leiomyoma by two different doses of mifepristone","volume":"31","author":"Yang","year":"1996","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R14-44-20210309","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9378(12)91826-8","article-title":"The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study","volume":"170","author":"Reinsch","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R15-44-20210309","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R16-44-20210309","first-page":"490","article-title":"A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone","volume":"33","author":"Zeng","year":"1998","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R17-44-20210309","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1701-2163(16)30582-5","article-title":"The management of uterine leiomyomas","volume":"25","author":"Lefebvre","year":"2003","journal-title":"J Obstet Gynaecol Canada"},{"key":"R18-44-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstet Gynecol"},{"key":"R19-44-20210309","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1479-828X.2008.00931.x","article-title":"Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial","volume":"49","author":"Bagaria","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R20-44-20210309","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/oxfordjournals.humrep.a019153","article-title":"Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero","volume":"11","author":"Salle","year":"1996","journal-title":"Human Reprod"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:51Z","timestamp":1620960231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702170-00044"}},"subtitle":["A multicenter randomized controlled trial"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006124","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}